.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Federal Trade Commission
Covington
Teva
McKesson
Fish and Richardson
Colorcon
McKinsey
Daiichi Sankyo
Moodys

Generated: December 13, 2017

DrugPatentWatch Database Preview

Cefditoren pivoxil - Generic Drug Details

« Back to Dashboard

What are the generic sources for cefditoren pivoxil and what is the scope of cefditoren pivoxil freedom to operate?

Cefditoren pivoxil
is the generic ingredient in one branded drug marketed by Vansen Pharma and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Cefditoren pivoxil has seventeen patent family members in fifteen countries.

There are six drug master file entries for cefditoren pivoxil. Two suppliers are listed for this compound.

Summary for cefditoren pivoxil

Pharmacology for cefditoren pivoxil

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Vansen PharmaSPECTRACEFcefditoren pivoxilTABLET;ORAL021222-002Jul 21, 2008DISCNNoNo► Subscribe► Subscribe► SubscribeY► Subscribe
Vansen PharmaSPECTRACEFcefditoren pivoxilTABLET;ORAL021222-001Aug 29, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: cefditoren pivoxil

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Vansen PharmaSPECTRACEFcefditoren pivoxilTABLET;ORAL021222-001Aug 29, 2001► Subscribe► Subscribe
Vansen PharmaSPECTRACEFcefditoren pivoxilTABLET;ORAL021222-002Jul 21, 2008► Subscribe► Subscribe
Vansen PharmaSPECTRACEFcefditoren pivoxilTABLET;ORAL021222-002Jul 21, 2008► Subscribe► Subscribe
Vansen PharmaSPECTRACEFcefditoren pivoxilTABLET;ORAL021222-001Aug 29, 2001► Subscribe► Subscribe
Vansen PharmaSPECTRACEFcefditoren pivoxilTABLET;ORAL021222-001Aug 29, 2001► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: cefditoren pivoxil

Country Document Number Estimated Expiration
Mexico9802849► Subscribe
European Patent Office0862915► Subscribe
Germany69620220► Subscribe
Argentina004014► Subscribe
Spain2174109► Subscribe
Hungary9900609► Subscribe
Taiwan458778► Subscribe
Brazil9610836► Subscribe
Hungary224922► Subscribe
Portugal862915► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Accenture
Cipla
Johnson and Johnson
Queensland Health
Dow
Deloitte
Daiichi Sankyo
US Department of Justice
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot